Effects of anti-viral agent on survival and liver related mortality in patients with chronic hepatitis B virus: a systematic review study
Not Applicable
Recruiting
- Conditions
- Certain infectious and parasitic diseases
- Registration Number
- KCT0002363
- Lead Sponsor
- Hanyang University Seoul Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
1. Inclusion criteria
1) patients who were prescribed oral antiviral agents for a treatment of CHB during the study period
2) CHB patients with episode of liver decompensation defined as the occurence of complications such as refractory ascites, variceal bleeding, encephalopathy, or hepatorenal syndrome.
3) patients of any age of either sex
Exclusion Criteria
2. Exclusion criteria
1) patients who were diagnosted with all cancer before a treatment of CHB
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method survival analysis according to the medication compliance of antiviral agents
- Secondary Outcome Measures
Name Time Method reccurence rate analysis of decompensated liver cirrhosis complication according to the medication compliance of antiviral agents